UNSPSC 51183506: Benfosformin anhydrous

This classification denotes the anhydrous form of an anti-diabetic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 49030P3C8S. European Medicines Agency schedules Benfosformin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05715MIG. Benfosformin generally arises in the molecular formula C9H12N5O3P.2NA.H2O.

UNSPSC 51183506 Benfosformin anhydrous is a Commodity code for a specific pharmaceutical active ingredient rarely or not at all present in recent state and local procurement activity. No current state and local contract opportunities under this code appear in the available recent-opportunities dataset.

The code represents a niche pharmaceutical input with minimal practical relevance to state and local procurement workflows. School districts, counties, municipalities, and state health departments do not typically solicit raw pharmaceutical active ingredients; procurement at the state and local level focuses on finished pharmaceutical products through established group purchasing arrangements, direct purchase agreements with wholesalers, or state pharmacy benefit manager contracts. The absence of recent opportunities under this code reflects the structural mismatch between state and local purchasing patterns and the upstream pharmaceutical manufacturing supply chain that this Commodity code addresses.